Skip to main content
. 2017 Aug 4;24(8):e00062-17. doi: 10.1128/CVI.00062-17

TABLE 3.

ORs of peripartum HIV-1 MTCT for remaining maternal Env-specific humoral immune responses (secondary analysis)

Antigen OR (95% CI)a Uncorrected P valueb Corrected P valueb
1086Cgp140 1.12 (0.55–2.28) 0.75 0.86
1086D7 gp120K160N 1.21 (0.58–2.52) 0.62 0.79
4403 BMC5 gp120 7.20 (0.96–54.07) 0.06 0.10
A244 gp120 gDneg/293F 1.93 (0.85–4.42) 0.12 0.19
B.con env03 gp140_CF 1.25 (0.57–2.73) 0.58 0.79
Bio-MPER656 1.27 (0.84–1.93) 0.26 0.40
Bio-V2.1086C 1.03 (0.71–1.51) 0.87 0.90
Bio-V2.B 1.07 (0.67–1.73) 0.78 0.86
Bio-V3.B 1.10 (0.60–2.01) 0.76 0.86
Con6gp120/B 3.04 (0.76–12.18) 0.12 0.19
ConC_gp120_WT 2.12 (0.83–5.39) 0.12 0.19
gp70 MNV3 0.90 (0.59–1.36) 0.61 0.79
gp70B.caseA V1V2/293F 1.51 (1.00–2.28) 0.05 0.10
gp70_B.caseA2_V1V2/169K 1.37 (0.94–2.00) 0.10 0.18
gp70_C.1086CV1/V2 1.62 (1.08–2.44) 0.02 0.04
a

Adjusted for maternal CD4+ T cell count and maternal viral load. 95% CI, 95% confidence interval.

b

Humoral immune variable interactions with corrected P value of <0.05 are in bold font.